STK38 is a critical upstream regulator of MYC’s oncogenic activity in human B-cell lymphoma
Brygida Bisikirska(Columbia University Irving Medical Center), Andrea Califano(Columbia University Irving Medical Center)
Cited by 61
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Toward understanding and exploiting tumor heterogeneity
|Nature Medicine|2015|770
Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and Human
|Circulation|2020|617
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
|Science Translational Medicine|2019|316